Mandvi Bharadwaj

4.6k total citations · 1 hit paper
52 papers, 3.6k citations indexed

About

Mandvi Bharadwaj is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Mandvi Bharadwaj has authored 52 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 18 papers in Epidemiology and 14 papers in Oncology. Recurrent topics in Mandvi Bharadwaj's work include Immune Cell Function and Interaction (21 papers), Viral-associated cancers and disorders (11 papers) and Hepatitis C virus research (11 papers). Mandvi Bharadwaj is often cited by papers focused on Immune Cell Function and Interaction (21 papers), Viral-associated cancers and disorders (11 papers) and Hepatitis C virus research (11 papers). Mandvi Bharadwaj collaborates with scholars based in Australia, United States and United Kingdom. Mandvi Bharadwaj's co-authors include Jamie Rossjohn, James McCluskey, Lars Kjer‐Nielsen, Anthony W. Purcell, Rajiv Khanna, Scott R. Burrows, Lyudmila Kostenko, Patricia T. Illing, Zhenjun Chen and Dale I. Godfrey and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Mandvi Bharadwaj

50 papers receiving 3.5k citations

Hit Papers

Immune self-reactivity triggered by drug-modified HLA-pep... 2012 2026 2016 2021 2012 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mandvi Bharadwaj Australia 28 2.0k 1.1k 716 585 466 52 3.6k
Lyudmila Kostenko Australia 18 3.0k 1.5× 586 0.5× 484 0.7× 505 0.9× 503 1.1× 27 3.9k
Stéphanie Gras Australia 43 4.6k 2.3× 1.0k 1.0× 1.0k 1.4× 344 0.6× 1.4k 2.9× 122 5.9k
J.P. Vivian Australia 28 1.6k 0.8× 240 0.2× 415 0.6× 358 0.6× 632 1.4× 55 2.6k
Vincenzo Barnaba Italy 42 3.7k 1.9× 1.7k 1.6× 1.0k 1.5× 71 0.1× 1.2k 2.6× 148 6.5k
Bernard Maillère France 34 1.8k 0.9× 437 0.4× 601 0.8× 127 0.2× 1.2k 2.5× 141 3.7k
Hernán Valdez United States 43 2.5k 1.2× 1.4k 1.3× 671 0.9× 75 0.1× 341 0.7× 154 7.1k
Neil Steven United Kingdom 34 2.5k 1.3× 1.3k 1.2× 3.7k 5.2× 71 0.1× 948 2.0× 93 5.7k
Patrick Haslett United States 32 1.2k 0.6× 785 0.7× 831 1.2× 83 0.1× 1.5k 3.2× 57 4.3k
JE Groopman United States 34 1.5k 0.7× 755 0.7× 793 1.1× 83 0.1× 604 1.3× 55 4.5k
Robbert G. M. Bredius Netherlands 37 1.8k 0.9× 950 0.9× 698 1.0× 227 0.4× 721 1.5× 128 4.3k

Countries citing papers authored by Mandvi Bharadwaj

Since Specialization
Citations

This map shows the geographic impact of Mandvi Bharadwaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandvi Bharadwaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandvi Bharadwaj more than expected).

Fields of papers citing papers by Mandvi Bharadwaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandvi Bharadwaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandvi Bharadwaj. The network helps show where Mandvi Bharadwaj may publish in the future.

Co-authorship network of co-authors of Mandvi Bharadwaj

This figure shows the co-authorship network connecting the top 25 collaborators of Mandvi Bharadwaj. A scholar is included among the top collaborators of Mandvi Bharadwaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandvi Bharadwaj. Mandvi Bharadwaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grant, Emma J., Tracy M. Josephs, Liyen Loh, et al.. (2018). Broad CD8+ T cell cross-recognition of distinct influenza A strains in humans. Nature Communications. 9(1). 5427–5427. 55 indexed citations
2.
Grant, Emma J., Tracy M. Josephs, Sophie A. Valkenburg, et al.. (2016). Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures. Journal of Biological Chemistry. 291(47). 24335–24351. 19 indexed citations
3.
Sacks‐Davis, Rachel, Campbell Aitken, Peter Higgs, et al.. (2013). High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study. PLoS ONE. 8(11). e80216–e80216. 57 indexed citations
4.
Illing, Patricia T., J.P. Vivian, Nadine L. Dudek, et al.. (2012). Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature. 486(7404). 554–558. 513 indexed citations breakdown →
5.
Reantragoon, Rangsima, Lars Kjer‐Nielsen, Onisha Patel, et al.. (2012). Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. The Journal of Experimental Medicine. 209(4). 761–774. 147 indexed citations
6.
Kostenko, Lyudmila, Lars Kjer‐Nielsen, I. Nicholson, et al.. (2011). Rapid screening for the detection of HLA‐B57 and HLA‐B58 in prevention of drug hypersensitivity. Tissue Antigens. 78(1). 11–20. 34 indexed citations
7.
Miles, John J., Usha K. Nivarthi, Lars Kjer‐Nielsen, et al.. (2010). Antigen-Driven Patterns of TCR Bias Are Shared across Diverse Outcomes of Human Hepatitis C Virus Infection. The Journal of Immunology. 186(2). 901–912. 22 indexed citations
8.
Macdonald, W.A., Zhenjun Chen, Stéphanie Gras, et al.. (2009). T Cell Allorecognition via Molecular Mimicry. Immunity. 31(6). 897–908. 211 indexed citations
9.
Yotnda, Patricia, Campbell Aitken, L. Earnest-Silveira, et al.. (2008). Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response. Clinical Immunology. 128(3). 329–339. 16 indexed citations
10.
Kostenko, Lyudmila, Anthony W. Purcell, Nicholas A. Williamson, et al.. (2008). Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity. Immunity. 28(6). 822–832. 248 indexed citations
11.
Kostenko, Lyudmila, Anthony W. Purcell, Nicholas A. Williamson, et al.. (2008). Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity. Immunity. 29(1). 165–165. 1 indexed citations
12.
McCluskey, James, Lyudmila Kostenko, Anthony W. Purcell, et al.. (2007). Abacavir hypersensitivity in HLA-B57-positive individuals with HIV infection is dependent upon the conventional MHC-I Ag presentation pathway. Murdoch Research Repository (Murdoch University). 69(5). 5 indexed citations
13.
Purcell, Anthony W., W.A. Macdonald, Lars Kjer‐Nielsen, et al.. (2004). Natural HLA Class I Polymorphism Controls the Pathway of Antigen Presentation and Susceptibility to Viral Evasion. The Journal of Experimental Medicine. 200(1). 13–24. 135 indexed citations
14.
Gowans, Eric J., Kathryn Jones, Mandvi Bharadwaj, & David C. Jackson. (2004). Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. Journal of Clinical Virology. 30(4). 283–290. 29 indexed citations
15.
Belz, Gabrielle T., Christopher M. Smith, Mandvi Bharadwaj, Alison Rice, & David C. Jackson. (2004). DCs as targets for vaccine design. Cytotherapy. 6(2). 88–98. 27 indexed citations
16.
Sherritt, Martina A., Mandvi Bharadwaj, Jacqueline M. Burrows, et al.. (2003). Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy. Transplantation. 75(9). 1556–1560. 74 indexed citations
17.
Bharadwaj, Mandvi & Denis J. Moss. (2002). Epstein-Barr virus vaccine: a cytotoxic T-cell-based approach. Expert Review of Vaccines. 1(4). 467–476. 4 indexed citations
18.
Bharadwaj, Mandvi, Martina A. Sherritt, Rajiv Khanna, & Denis J. Moss. (2001). Contrasting Epstein–Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design. Vaccine. 19(27). 3769–3777. 19 indexed citations
19.
Nath, Indira, Alagarsamy Lakku Reddi, Mandvi Bharadwaj, et al.. (2000). Dysregulation of IL-4 expression in lepromatous leprosy patients with and without erythema nodosum leprosum. Leprosy Review. 71. S130–7. 9 indexed citations
20.
Mathur, A, et al.. (1988). Immunopathological study of spleen during Japanese encephalitis virus infection in mice.. PubMed. 69(3). 423–32. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026